Protecting Our Infants Act of 2015

Bill: 114-hr-1462
Sponsor: Rep. Clark, Katherine M. [D-MA-5]
Introduced: 2015-03-19 in the House
Policy area: Health
Subjects: Child health
Congressional oversight
Drug, alcohol, tobacco use
Government information and archives
Government studies and investigations
Health care coverage and access
Health information and medical records
Health promotion and preventive care
Medical research
Sex and reproductive health
Women's health

Summary:
action_date: 2015-03-19
text: 

Protecting Our Infants Act of 2015

 
This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:
 
 
an assessment of existing research on neonatal abstinence syndrome;
 
an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
 
an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
 
recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.
 
 
The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.
 The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.
action_date: 2015-09-08
text: 
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
 

Protecting Our Infants Act of 2015

 
(Sec. 3) This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:
 
 
an assessment of existing research on neonatal abstinence syndrome;
 
an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
 
an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
 
recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.
 
 
(Sec. 4) The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.
 (Sec. 5) The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.

Legislative actions:
action_date: 2016-07-14
text: Indefinitely postponed by Senate by Unanimous Consent. (consideration: CR S5195)
action_date: 2015-09-09
text: Received in the Senate.
action_date: 2015-09-08
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2015-09-08
text: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5798-5799)
action_date: 2015-09-08
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5798-5799)
action_date: 2015-09-08
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 1462.
action_date: 2015-09-08
text: Considered under suspension of the rules. (consideration: CR H5798-5801)
action_date: 2015-09-08
text: Mr. Guthrie moved to suspend the rules and pass the bill.
action_date: 2015-09-08
text: Placed on the Union Calendar, Calendar No. 185.
action_date: 2015-09-08
text: Reported by the Committee on Energy and Commerce. H. Rept. 114-244.
action_date: 2015-09-08
text: Reported by the Committee on Energy and Commerce. H. Rept. 114-244.
action_date: 2015-07-29
text: Ordered to be Reported by Voice Vote.
action_date: 2015-07-29
text: Committee Consideration and Mark-up Session Held.
action_date: 2015-07-23
text: Forwarded by Subcommittee to Full Committee by Voice Vote .
action_date: 2015-07-23
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2015-03-20
text: Referred to the Subcommittee on Health.
action_date: 2015-03-19
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-03-19
text: Introduced in House
action_date: 2015-03-19
text: Introduced in House